3-Substituted Coumarins Inhibit NorA and MepA Efflux Pumps of <i>Staphylococcus aureus</i>

• Main Authors: José B. de Araújo-Neto (Author), Cícera D. de M. Oliveira-Tintino (Author), Gildênia A. de Araújo (Author), Daniel S. Alves (Author), Fernanda R. Ribeiro (Author), Guilherme A. Brancaglion (Author), Diogo T. Carvalho (Author), Clara Mariana Gonçalves Lima (Author), Hani S. H. Mohammed Ali (Author), Irfan A. Rather (Author), Mohmmad Y. Wani (Author), Talha B. Emran (Author), Henrique D. M. Coutinho (Author), Valdir de Q. Balbino (Author), Saulo R. Tintino (Author)
• Format: Book
• Published: MDPI AG, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Coumarins are compounds with scientifically proven antibacterial properties, and modifications to the chemical structure are known to improve their effects. This information is even more relevant with the unbridled advances of antibiotic resistance, where <i>Staphylococcus aureus</i> and its efflux pumps play a prominent role. The study's objective was to evaluate the potential of synthetic coumarins with different substitutions in the C-3 position as possible inhibitors of the NorA and MepA efflux pumps of <i>S. aureus</i>. For this evaluation, the following steps took place: (i) the determination of the minimum inhibitory concentration (MIC); (ii) the association of coumarins with fluoroquinolones and ethidium bromide (EtBr); (iii) the assessment of the effect on EtBr fluorescence emission; (iv) molecular docking; and (v) an analysis of the effect on membrane permeability. Coumarins reduced the MICs of fluoroquinolones and EtBr between 50% and 87.5%. Coumarin C1 increased EtBr fluorescence emission between 20 and 40% by reinforcing the evidence of efflux inhibition. The molecular docking results demonstrated that coumarins have an affinity with efflux pumps and establish mainly hydrogen bonds and hydrophobic interactions. Furthermore, C1 did not change the permeability of the membrane. Therefore, we conclude that these 3-substituted coumarins act as inhibitors of the NorA and MepA efflux pumps of <i>S. aureus</i>.

Item Description

10.3390/antibiotics12121739
2079-6382